Announcements Trials
Browse Landscape

Phase

Phase 2 13Phase 3 5Phase 1 3Phase 1/2 2Phase NA 1Phase 4 1Phase 2/3 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Colorectal Neoplasms 11Keratosis, Actinic 5Stomach Neoplasms 3Head and Neck Neoplasms 3Breast Neoplasms 3Neoplasm Metastasis 2Liver Neoplasms 2Esophageal Neoplasms 2Colonic Neoplasms 2Stage-â…¡ Colorectal Cancer 1Skin Neoplasms 1Skin Diseases 1Rectal Neoplasms 1Postoperative Complications 1Pancreatic Neoplasms 1Neutropenia 1Neoplasms, Squamous Cell 1Neoplasms, Basal Cell 1Neoplasms by Site 1Neoplasms 1Carcinoma, Squamous Cell 1Carcinoma, Neuroendocrine 1Carcinoma, Basal Cell 1Carcinoma 1Bowen's Disease 1Anus Neoplasms 1Adenocarcinoma Of Esophagus 1

Interventions

Oxaliplatin 1Fluorouracil 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 4 × Anus Neoplasms × Fluorouracil × Clear all
NCT04269369 2020-02-13

Implementation of Pre-emptive Geno- and Phenotyping in 5-Fluorouracil- or Capecitabine-treated Patients

Jessa Hospital

Phase 4 Unknown
250 enrolled
Gastrointestinal

Anus Neoplasms, Colonic Neoplasms, Esophageal Neoplasms, Pancreatic Neoplasms, Stomach Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡